menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Moving Toward Synthetic Alternatives to Heparin

Program Information
Recommended
Moving Toward Synthetic Alternatives to Heparin
RestartResume
With ongoing questions about the manufacturing of heparin in China and concerns about a potential shortage of the anticoagulant...
  • Overview

    With ongoing questions about the manufacturing of heparin in China and concerns about a potential shortage of the anticoagulant, some are wondering whether there is a need for new heparin alternatives. Dr. Ted Love, chief executive officer of the San Francisco biotech company Nuvelo, tells host Bruce Japsen about the biotech industry's pursuit of synthetic variations of the popular blood thinner.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/15/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.